Under Vioxx Fire, Merck Faces Fosamax Claims Too

Law360, New York (July 11, 2006, 12:00 AM EDT) -- With trials over the potential side effects of Merck & Co.’s former blockbuster Vioxx underway, the pharmaceutical giant may soon be headed to court on charges related to its second-biggest seller, Fosamax, in a slew of class action suits that allege the osteoporosis drug could lead to jaw deterioration.

Since April, plaintiffs firm Levin Papantonio Thomas Mitchell Echsner & Proctor PA has filed more than two dozen lawsuits in Florida federal court over the drug.

Timothy O’Brien, lead attorney in the Florida cases, told the L.A....
To view the full article, register now.